The Problem LifeSavr Where It Helps Development Stage Team Work With Us

Not On My Watch

Earlier overdose recognition in supported accommodation.

LifeSavr is a chest-worn wearable system in development by NOMW Health, designed to identify signs associated with opioid overdose and alert designated responders so action can be taken sooner.

Our initial focus is supported accommodation settings, where people may use substances alone while staff are elsewhere in the building.

Prototype development completed.

Developed with expertise from health, academic and innovation organisations

NHS Scotland Chief Scientist Office University of Edinburgh University of Southampton Health Innovation South East Scotland (HISES) Office for Life Sciences
LifeSavr Prototype
2,551

Deaths involving opioids

England & Wales · ONS

1,172

Drug-misuse deaths

Scotland · NRS

Naloxone Overdose can be reversed when given in time
Earlier recognition Supports faster staff response in staffed settings

Sources: ONS · National Records of Scotland

The Problem

Many overdose deaths occur because recognition comes too late

Many overdose deaths are preventable when deterioration is recognised in time.

Naloxone can reverse opioid overdose, but only if someone recognises the danger and is able to respond quickly.

In supported accommodation settings, residents may be in private rooms while staff are elsewhere in the building. An overdose can go unnoticed until it is too late to respond effectively.

The Solution

A wearable system designed for earlier recognition and response

LifeSavr is a chest-worn wearable system designed to monitor physiological signals associated with opioid overdose.

When the system detects a pattern consistent with overdose risk, it is designed to trigger an alert so a designated responder can check on the person and take action.

LifeSavr is intended to support existing overdose response pathways. It is not a replacement for naloxone, clinical judgement, or emergency escalation. Its role is to help recognition happen sooner.

Continuous sensing while worn

Detection of patterns associated with overdose risk

Alert to designated responders

The aim: support earlier recognition of suspected overdose so designated staff can respond more quickly.

LifeSavr Prototype

Intended Setting

Why we are starting in supported accommodation

LifeSavr is being developed first for supported accommodation and hostel environments. These services support residents who may be at increased risk of overdose.

Overdoses often occur when someone is alone and recognition can be delayed. In supported accommodation, residents may spend time in private rooms while staff or support workers are elsewhere in the building.

This creates an environment where earlier recognition could enable someone nearby to check on a resident and respond.

Overdose risk increases when someone is alone

When a person is in a private room, recognition of a medical emergency may be delayed.

Staff or support workers are present within the service

Supported accommodation services often have staff on site or visiting support, enabling someone nearby to check on a resident if assistance is needed.

Development Stage

We are moving into real-world verification

LifeSavr prototype development has been completed. Work to date has included device engineering, structured engagement with people who use drugs and frontline service staff, and iterative refinement of both the device and the intended operating model.

We are now working with partner organisations to assess real-world performance, service workflows, and practical deployment within staffed accommodation environments.

Discuss a Pilot or Verification Partnership

Current status

Prototype completed
Real-world pilot with partner organisations
Regulatory approval and commercial launch

Background

Built through multidisciplinary collaboration

LifeSavr is being developed in collaboration with some of the UK's leading clinical, academic, and public health organisations.

Our founding team combines clinical expertise in opioid pharmacology and operating theatre practice, senior programme leadership within global pharmaceutical companies, and board-level experience in harm reduction. Academic partners have been selected from universities actively leading research in this field.

We are deliberate about who we work with. Everyone involved brings direct, credible experience of the clinical, technical, and systemic challenges we are here to address.

Organisations Involved in Development

NHS Scotland Chief Scientist Office University of Edinburgh University of Southampton Health Innovation South East Scotland Office for Life Sciences

Collaboration

We are looking for pilot and service partners

We are seeking conversations with organisations interested in helping shape the next stage of LifeSavr's development.

This includes local authorities, supported accommodation providers, homelessness services, public health teams, and research partners with an interest in verification activity, service design, or pilot work in staffed settings.

Contact NOMW Health
  • Local authorities
  • Supported accommodation providers
  • Homelessness and inclusion health services
  • Public health teams
  • Research and evaluation partners

Address

NOMW Health Limited · Bayes Centre, University of Edinburgh · 47 Potterrow · Edinburgh EH8 9BT